JPH053863B2 - - Google Patents
Info
- Publication number
- JPH053863B2 JPH053863B2 JP9947086A JP9947086A JPH053863B2 JP H053863 B2 JPH053863 B2 JP H053863B2 JP 9947086 A JP9947086 A JP 9947086A JP 9947086 A JP9947086 A JP 9947086A JP H053863 B2 JPH053863 B2 JP H053863B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- reaction
- formula
- disubstituted
- octanes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- -1 6,7-disubstituted-2-hydroxy-3-methylenebicyclo[3.3.0]octanes Chemical class 0.000 claims description 52
- 150000001875 compounds Chemical class 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 19
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical group [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 239000003638 chemical reducing agent Substances 0.000 claims description 12
- VBTCAHMANZTRMG-UHFFFAOYSA-N prop-2-ynylcyclopentane Chemical class C#CCC1CCCC1 VBTCAHMANZTRMG-UHFFFAOYSA-N 0.000 claims description 12
- 238000007363 ring formation reaction Methods 0.000 claims description 10
- 239000004215 Carbon black (E152) Substances 0.000 claims description 9
- 229930195733 hydrocarbon Natural products 0.000 claims description 9
- 229910052751 metal Inorganic materials 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 9
- 239000011701 zinc Substances 0.000 claims description 8
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 229910052783 alkali metal Inorganic materials 0.000 claims description 6
- 150000001340 alkali metals Chemical group 0.000 claims description 6
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 6
- 150000001342 alkaline earth metals Chemical group 0.000 claims description 6
- 238000010511 deprotection reaction Methods 0.000 claims description 5
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 4
- 229910052744 lithium Inorganic materials 0.000 claims description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- HIGZCTKLVJZSQN-UHFFFAOYSA-N 6-methylidene-2,3,3a,4,5,6a-hexahydro-1h-pentalene Chemical class C1CCC2C(=C)CCC21 HIGZCTKLVJZSQN-UHFFFAOYSA-N 0.000 claims 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 42
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 35
- 238000006243 chemical reaction Methods 0.000 description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 20
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
- 125000004430 oxygen atom Chemical group O* 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 239000012043 crude product Substances 0.000 description 9
- 239000007800 oxidant agent Substances 0.000 description 9
- FEJUGLKDZJDVFY-UHFFFAOYSA-N 9-borabicyclo(3.3.1)nonane Chemical compound C1CCC2CCCC1B2 FEJUGLKDZJDVFY-UHFFFAOYSA-N 0.000 description 8
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 125000005103 alkyl silyl group Chemical group 0.000 description 6
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- 230000035484 reaction time Effects 0.000 description 6
- 239000005051 trimethylchlorosilane Substances 0.000 description 6
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 description 5
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 238000006197 hydroboration reaction Methods 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 5
- 235000019341 magnesium sulphate Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000012267 brine Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000012372 hydroboration reagent Substances 0.000 description 4
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- 238000010908 decantation Methods 0.000 description 3
- 238000005828 desilylation reaction Methods 0.000 description 3
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 3
- 238000004811 liquid chromatography Methods 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- HCHKCACWOHOZIP-AKLPVKDBSA-N zinc-68 Chemical class [68Zn] HCHKCACWOHOZIP-AKLPVKDBSA-N 0.000 description 3
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 description 2
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 2
- CDKCEZNPAYWORX-UHFFFAOYSA-N 1-tert-butyl-4-(4-tert-butylphenyl)benzene Chemical group C1=CC(C(C)(C)C)=CC=C1C1=CC=C(C(C)(C)C)C=C1 CDKCEZNPAYWORX-UHFFFAOYSA-N 0.000 description 2
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 2
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 2
- 125000005916 2-methylpentyl group Chemical group 0.000 description 2
- CLPCXIOMHWOYBD-UHFFFAOYSA-N 2-prop-2-ynylcyclopentan-1-one Chemical class O=C1CCCC1CC#C CLPCXIOMHWOYBD-UHFFFAOYSA-N 0.000 description 2
- JANVYOZZTKSZGN-WCAFQOMDSA-N 5-[(3as,5r,6r,6as)-5-hydroxy-6-[(e,3s)-3-hydroxyoct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]pentanoic acid Chemical compound C1=C(CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 JANVYOZZTKSZGN-WCAFQOMDSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XZFRIPGNUQRGPI-WLPVIMDJSA-N Carbacyclin Chemical compound C1\C(=C\CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 XZFRIPGNUQRGPI-WLPVIMDJSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- TWJVNKMWXNTSAP-UHFFFAOYSA-N azanium;hydroxide;hydrochloride Chemical class [NH4+].O.[Cl-] TWJVNKMWXNTSAP-UHFFFAOYSA-N 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 125000006267 biphenyl group Chemical group 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 2
- 150000001940 cyclopentanes Chemical class 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- ZOYIRSVTXOTVSM-UHFFFAOYSA-N dipentylborane Chemical compound CCCCCBCCCCC ZOYIRSVTXOTVSM-UHFFFAOYSA-N 0.000 description 2
- 239000004210 ether based solvent Substances 0.000 description 2
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 239000008177 pharmaceutical agent Substances 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 2
- CKPKEQOGKBPTSV-UHFFFAOYSA-M sodium;hydrogen peroxide;hydroxide Chemical compound [OH-].[Na+].OO CKPKEQOGKBPTSV-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000006053 2-methyl-3-pentenyl group Chemical group 0.000 description 1
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000006042 4-hexenyl group Chemical group 0.000 description 1
- CTBUCCBJSBPHEZ-UHFFFAOYSA-M CO.[F-].[K+] Chemical compound CO.[F-].[K+] CTBUCCBJSBPHEZ-UHFFFAOYSA-M 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- MNIAFJJPAAHXBR-UHFFFAOYSA-N OC12CC(CC2CCC1)=C Chemical class OC12CC(CC2CCC1)=C MNIAFJJPAAHXBR-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- UORVGPXVDQYIDP-BJUDXGSMSA-N borane Chemical class [10BH3] UORVGPXVDQYIDP-BJUDXGSMSA-N 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- ZDQWVKDDJDIVAL-UHFFFAOYSA-N catecholborane Chemical compound C1=CC=C2O[B]OC2=C1 ZDQWVKDDJDIVAL-UHFFFAOYSA-N 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 229940117975 chromium trioxide Drugs 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical class O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- HOFWRLQWIZPYEH-UHFFFAOYSA-J dibromomethane;tetrachlorotitanium;zinc Chemical compound [Zn].BrCBr.Cl[Ti](Cl)(Cl)Cl HOFWRLQWIZPYEH-UHFFFAOYSA-J 0.000 description 1
- XNYOSXARXANYPB-UHFFFAOYSA-N dicyclohexylborane Chemical compound C1CCCCC1BC1CCCCC1 XNYOSXARXANYPB-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- WHFKIZXBVFEJGA-UHFFFAOYSA-L dihydroxy(dioxo)chromium;pyridine Chemical compound O[Cr](O)(=O)=O.C1=CC=NC=C1.C1=CC=NC=C1 WHFKIZXBVFEJGA-UHFFFAOYSA-L 0.000 description 1
- NZZFYRREKKOMAT-UHFFFAOYSA-N diiodomethane Chemical compound ICI NZZFYRREKKOMAT-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 150000002084 enol ethers Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- VVNXEADCOVSAER-UHFFFAOYSA-N lithium sodium Chemical compound [Li].[Na] VVNXEADCOVSAER-UHFFFAOYSA-N 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 238000005822 methylenation reaction Methods 0.000 description 1
- CRUCMBRORARQSI-UHFFFAOYSA-N methylsulfinylsulfinylmethane Chemical compound CS(=O)S(C)=O CRUCMBRORARQSI-UHFFFAOYSA-N 0.000 description 1
- AJUXDFHPVZQOGF-UHFFFAOYSA-N n,n-dimethyl-1-naphthylamine Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1 AJUXDFHPVZQOGF-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 150000002900 organolithium compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- KBBYYFOMJKSRSM-UHFFFAOYSA-N potassium;cyanide;hydrate Chemical compound O.[K+].N#[C-] KBBYYFOMJKSRSM-UHFFFAOYSA-N 0.000 description 1
- LUMVCLJFHCTMCV-UHFFFAOYSA-M potassium;hydroxide;hydrate Chemical compound O.[OH-].[K+] LUMVCLJFHCTMCV-UHFFFAOYSA-M 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003174 prostaglandin I2 derivatives Chemical class 0.000 description 1
- KAQKFAOMNZTLHT-OZUDYXHBSA-M prostaglandin I2(1-) Chemical compound O1\C(=C/CCCC([O-])=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-OZUDYXHBSA-M 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
- 229940071536 silver acetate Drugs 0.000 description 1
- ZEQXOGPEPLEMIS-UHFFFAOYSA-N silver;ethanol;nitrate;hydrate Chemical compound O.[Ag+].CCO.[O-][N+]([O-])=O ZEQXOGPEPLEMIS-UHFFFAOYSA-N 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 description 1
- UYPYRKYUKCHHIB-UHFFFAOYSA-N trimethylamine N-oxide Chemical compound C[N+](C)(C)[O-] UYPYRKYUKCHHIB-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
<産業上の利用分野>
本発明はプロパルギルシクロペンタン類を用い
る6,7−二置換−2−ヒドロキシ−3−メチレ
ンビシクロ[3.3.0]オクタン類の製造法に関す
る。更に詳細には9(O)−メタノ−Δ6(9a)−プロ
スタグランジンI1類の新規な鍵合成中間体である
6,7−二置換−2−ヒドロキシ−3−メチレン
ビシクロ[3.3.0]オクタン類の製造法に関する。DETAILED DESCRIPTION OF THE INVENTION <Industrial Application Field> The present invention relates to a method for producing 6,7-disubstituted-2-hydroxy-3-methylenebicyclo[3.3.0]octanes using propargylcyclopentanes. More specifically , 6,7 -disubstituted- 2 -hydroxy-3-methylenebicyclo [3.3. 0] Regarding the production method of octanes.
<従来の技術>
カルバサイクリンは生体内生理活性物質である
プロスタグランジン(PGと略記することがある)
I2(PGI2)の6,9一位の酸素原子がメチレン基
で置換されたプロスタグランジンI2類縁体であ
り、分子内にエノールエーテルの部分構造を有す
る天然のプロスタグランジンI2に比較して化学的
に安定であるために抗血栓剤等の医薬品として有
用な化合物である。近年、カルバサイクリンの二
重結合異性体の一種であるイソカルバサイクリ
ン、すなわち、9(O)−メタノ−Δ6(9a)−プロス
タグランジンI1類が、この同族体の中でも最も強
い血小板凝集抑制作用を示すことが発見され、医
薬品としての応用が期待されるようになつた〔池
上ら,テトラヘドロン・レターズ(Tetrahedron
Letters),33,3493および3497(1983)参照〕。<Conventional technology> Carbacyclin is a prostaglandin (sometimes abbreviated as PG), which is a physiologically active substance in the body.
I 2 (PGI 2 ) is a prostaglandin I 2 analog in which the oxygen atom at the 6,9-1 position is substituted with a methylene group, and is a natural prostaglandin I 2 that has an enol ether partial structure in the molecule. Comparatively, it is chemically stable, making it a useful compound as a pharmaceutical agent such as an antithrombotic agent. In recent years, isocarbacyclin, a type of double-bond isomer of carbacyclin, i.e., 9(O)-methano-Δ 6(9a) -prostaglandin I class 1 , has been shown to have the strongest platelet aggregation potential among its congeners. It was discovered that it exhibits an inhibitory effect, and its application as a pharmaceutical was expected [Ikegami et al., Tetrahedron Letters]
Letters), 33 , 3493 and 3497 (1983)].
先に本発明者らはかかる9(O)−メタノ−
Δ6(9a)−プロスタグランジンI1(イソカルバサイク
リン)の鍵合成中間体として有用な6,7−二置
換−2−ヒドロキシ−3−メチレンビシクロ
[3.3.0]オクタン類とその製造法を特許出願し
た。その概要は次の通りである。 Previously, the present inventors discovered such 9(O)-methanol-
6,7-Disubstituted-2-hydroxy-3-methylenebicyclo[3.3.0]octanes useful as key synthetic intermediates of Δ 6(9a) -prostaglandin I 1 (isocarbacyclines) and their production method A patent application was filed. The outline is as follows.
この方法によればアリルアルコール(A)より
3工程を経てアリルアルコール(C)(6,7−
二置換−2−ヒドロキシ−3−メチレンビシクロ
[3.3.0]オクタン類)に誘導されるが、この間の
収率は50%で(A)の半分が失われることにな
る。この為より効率的なアリルアルコール(C)
(6,7−二置換−2−ヒドロキシ−3−メチレ
ンビシクロ[3.3.0]オクタン類)の合成法の開
発が望まれている。 According to this method, allyl alcohol (C) (6,7-
The yield is 50% and half of (A) is lost. This makes allyl alcohol (C) more efficient.
It is desired to develop a method for synthesizing (6,7-disubstituted-2-hydroxy-3-methylenebicyclo[3.3.0]octanes).
<発明が解決しようとする問題点>
本発明の目的は9(O)−メタノ−Δ6(9a)−プロ
スタグランジンI1類(イソカルバサイクリン類)
の有用な鍵中間体である。6,7−二置換−2−
ヒドロキシ−3−メチレンビシクロ[3.3.0]オ
クタン類の効率的な製造法を提供することにあ
る。<Problems to be Solved by the Invention> The purpose of the present invention is to solve 9(O)-methano- Δ6(9a) -prostaglandin I class 1 (isocarbacyclines)
is a useful key intermediate for 6,7-disubstituted-2-
An object of the present invention is to provide an efficient method for producing hydroxy-3-methylenebicyclo[3.3.0]octanes.
本発明者らは9(O)−メタノ−Δ6(9a)−プロス
タグランジンI1類(イソカルバサイクリン類)の
有用な合成鍵中間体である。6,7−二置換−2
−ヒドロキシ−3−メチレンビシクロ[3.3.0]
オクタン類の効率的な製造法を見出すべく鋭意研
究した結果、特定のプロパルギルシクロペンタノ
ン類を用い、これを還元剤により環化せしめるこ
とにより、目的とする6,7−二置換−2−ヒド
ロキシ−3−メチレンビシクロ[3.3.0]オクタ
ン類が効率的に得られることを見出し、本発明に
到達したものである。 We have found that 9(O)-methano-Δ 6(9a) -prostaglandin I 1 is a useful synthetic key intermediate (isocarbacyclines). 6,7-disubstituted-2
-Hydroxy-3-methylenebicyclo[3.3.0]
As a result of intensive research to find an efficient method for producing octanes, we found that by using specific propargylcyclopentanones and cyclizing them with a reducing agent, we were able to produce the desired 6,7-disubstituted-2-hydroxy The present invention was achieved by discovering that -3-methylenebicyclo[3.3.0]octanes can be efficiently obtained.
<問題を解決するための手段>
本発明では下記式〔〕
[式中、R11,R21は同一もしくは異なり、ト
リ(C1〜C7)炭化水素シリル基、を表わし、R3
は水素原子を表わし、R4は直鎖もしくは分岐鎖
C3〜C8アルキル基を表わし、nは0を表わす。]
で表わされる化合物およびその鏡像体あるいはそ
れらの任意の割合の混合物であるプロパルギルシ
クロペンタン類を金属種を用いる還元剤によつて
環化反応せしめ、また必要により脱保護反応せし
めることを特徴とする、下記式〔〕
[式中、R1,R2は同一もしくは異なり、水素
原子またはトリ(C1〜C7)炭化水素シリル基を
表わし、R3,R4およびnは前記定義に同じ。]
で表わされる化合物およびその鏡像体あるいはそ
れらの任意の割合の混合物である6,7−二置換
−2−ヒドロキシ−3−メチレンビシクロ
[3.3.0]オクタン類の製造法が提供される。<Means for solving the problem> In the present invention, the following formula [] [In the formula, R 11 and R 21 are the same or different and represent a tri(C 1 to C 7 ) hydrocarbon silyl group, and R 3
represents a hydrogen atom, R 4 is a straight or branched chain
It represents a C3 - C8 alkyl group, and n represents 0. ] A compound represented by the formula and its enantiomers or propargylcyclopentanes, which are mixtures thereof in arbitrary proportions, are subjected to a cyclization reaction using a reducing agent using a metal species, and are also subjected to a deprotection reaction if necessary. , the following formula [] [In the formula, R 1 and R 2 are the same or different and represent a hydrogen atom or a tri(C 1 to C 7 ) hydrocarbon silyl group, and R 3 , R 4 and n are the same as defined above. ] A method for producing 6,7-disubstituted-2-hydroxy-3-methylenebicyclo[3.3.0]octanes, which is a compound represented by the following and its enantiomer or a mixture thereof in any proportion, is provided.
また本発明では上記製造法の原料となる下記式
〔〕
〔式中、R1,R2,R3,R4およびnは前記定義
に同じ〕で表わされる化合物およびその鏡像体あ
るいはそれらの任意の割合の混合物であるシクロ
ペンタン類が提供される。 In addition, in the present invention, the following formula [] is used as a raw material for the above production method. Provided are compounds represented by the formula [wherein R 1 , R 2 , R 3 , R 4 and n are the same as defined above] and their enantiomers, or cyclopentanes which are mixtures thereof in arbitrary proportions.
上記式〔〕においてR11およびR21は同一も
しくは異なり、トリ(C1〜C7)炭化水素シリル
基を表わすが、その他の例として水酸基の酸素原
子とともにアセタール結合を形成する基があげら
れる。 In the above formula [], R 11 and R 21 are the same or different and represent a tri(C 1 -C 7 ) hydrocarbon silyl group, and other examples include a group that forms an acetal bond with the oxygen atom of a hydroxyl group.
トリ(C1〜C7)炭化水素シリル基としては、
例えば、トリメチルシリル基,トリエチルシリル
基,トリイソプロピルシリル基,t−ブチルジメ
チル基のようなトリ(C1〜C4)アルキルシリル
基,t−ブチルジフエニルシリル基のようなジフ
エニル(C1〜C4)アルキルシリル基,ジメチル
フエニル基のようなジ(C1〜C4)アルキルフエ
ニル基、またはトリベンジルシリル基などを好ま
しいものとして挙げることができる。トリ(C1
〜C4)アルキルシリル,ジフエニル(C1〜C4)
アルキルシリル,フエニルジ(C1〜C4)アルキ
ルシリル基が好ましく、なかでもt−ブチルジメ
チルシリル基,トリメチルシリル基が特に好まし
い。 As a tri(C 1 - C 7 ) hydrocarbon silyl group,
For example, trimethylsilyl group, triethylsilyl group, triisopropylsilyl group, tri(C 1 -C 4 )alkylsilyl group such as t-butyldimethyl group, diphenyl(C 1 -C 4 )alkylsilyl group such as t-butyldiphenylsilyl group, 4 ) Preferable examples include an alkylsilyl group, a di(C 1 -C 4 )alkylphenyl group such as a dimethylphenyl group, and a tribenzylsilyl group. Tori (C 1
~ C4 ) Alkylsilyl, diphenyl ( C1 ~ C4 )
Alkylsilyl and phenyldi(C 1 -C 4 )alkylsilyl groups are preferred, and t-butyldimethylsilyl and trimethylsilyl groups are particularly preferred.
水酸基の酸素原子と共にアセタール結合を形成
する基としては、例えば、メトキシメチル基,1
−エトキシエチル基,2−メトキシ−2−プロピ
ル基,2−エトキシ−2−プロピル基,(2−メ
トキシエトキシ)メチル基,ベンジルオキシメチ
ル基,2−テトラヒドロピラニル基,2−テトラ
ヒドロフラニル基,または6,6−ジメチル−3
−オキサ−2−オキソビシクロ〔3.1.0〕ヘキス
−4−イル基を挙げることができる。2−テトラ
ヒドロピラニル基,2−テトラヒドロフラニル,
1−エトキシエチル,2−エトキシ−2−プロピ
ル,(2−メトキシエトキシ)メチル,6,6−
ジメチル−3−オキサ−2−オキソビシクロ
〔3.1.0〕ヘキス−4−イル基が特に好ましい。な
かでも2−テトラヒドロピラニル基が特に好まし
い。 Examples of groups that form an acetal bond with the oxygen atom of a hydroxyl group include methoxymethyl group, 1
-ethoxyethyl group, 2-methoxy-2-propyl group, 2-ethoxy-2-propyl group, (2-methoxyethoxy)methyl group, benzyloxymethyl group, 2-tetrahydropyranyl group, 2-tetrahydrofuranyl group, or 6,6-dimethyl-3
-oxa-2-oxobicyclo[3.1.0]hex-4-yl group may be mentioned. 2-tetrahydropyranyl group, 2-tetrahydrofuranyl,
1-ethoxyethyl, 2-ethoxy-2-propyl, (2-methoxyethoxy)methyl, 6,6-
Particularly preferred is dimethyl-3-oxa-2-oxobicyclo[3.1.0]hex-4-yl. Among them, 2-tetrahydropyranyl group is particularly preferred.
これらのシリル基およびアセタール結合を形成
する基は水酸基の保護基であると理解されるべき
である。これらの保護基は最終生成物の段階で弱
酸性から中性の条件で容易に除去されて薬剤とし
て有用な遊離の水酸基とすることができる。した
がつてこのような性状を有している水酸基の保護
基はシリル基やアセタール結合を形成する基の代
わりとして使用することができる。 It is to be understood that these silyl groups and groups forming acetal bonds are hydroxyl protecting groups. These protecting groups can be easily removed in the final product stage under mildly acidic to neutral conditions to form free hydroxyl groups useful as pharmaceuticals. Therefore, a hydroxyl protecting group having such properties can be used in place of a silyl group or a group forming an acetal bond.
上記式〔〕においてR3は水素原子を表わす
が、その他の例としてメチル基またはビニル基が
あげられる。上記時[]においてR4は直鎖も
しくは分岐鎖C3〜C8アルキル基を表わすが、そ
の他の例として酸素原子を含んだ直鎖もしくは分
岐鎖C3〜C8アルキル基;酸素原子を含んでもよ
いアルケニル基もしくはアルキニル基;置換もし
くは非置換のフエニル基;置換もしくは非置換の
フエノキシ基;置換もしくは非置換のC3〜C10シ
クロアルキル基;またはC1〜C6アルコキシ基置
換されていてもよいフエニル基,置換されていて
もよいフエノキシ基もしくは置換されていてもよ
いC3〜C10シクロアルキル基で置換されている直
鎖もしくは分岐鎖C1〜C5アルキル基があげられ
る。直鎖もしくは分岐鎖C3〜C8アルキル基とし
てはプロピロ基,ブチル基,ペンチル基、ヘキシ
ル基,ヘプチル基,2−ヘキシル基,2−メチル
−2−ヘキシル基,2−メチルブチル基,2−メ
チルペンチル基,2−メチルヘキシル基,2,2
−ジメチルヘキシル基などを挙げることができ
る。ブチル基,ベンチル基,ヘキシル基,ヘプチ
ル基,2−ヘキシル基,2−メチル−2−ヘキシ
ル基,2−メチルブチル基,2−メチルペンチル
基が好ましい。またそれに酸素原子を含むものと
しては、2−メトキシエチル基,2−エトキシエ
チル基があげられる。 In the above formula [], R 3 represents a hydrogen atom, but other examples include a methyl group or a vinyl group. In the above case [ ], R 4 represents a straight-chain or branched C 3 -C 8 alkyl group, but other examples include a straight-chain or branched C 3 -C 8 alkyl group containing an oxygen atom; a substituted or unsubstituted phenyl group; a substituted or unsubstituted phenoxy group; a substituted or unsubstituted C3 - C10 cycloalkyl group; or a C1 - C6 alkoxy group; Examples include a linear or branched C1-C5 alkyl group substituted with an optionally substituted phenyl group, an optionally substituted phenoxy group, or an optionally substituted C3-C10 cycloalkyl group . Straight-chain or branched C3 - C8 alkyl groups include propylo group, butyl group, pentyl group, hexyl group, heptyl group, 2-hexyl group, 2-methyl-2-hexyl group, 2-methylbutyl group, 2- Methylpentyl group, 2-methylhexyl group, 2,2
-dimethylhexyl group and the like. Preferred are a butyl group, a benzyl group, a hexyl group, a heptyl group, a 2-hexyl group, a 2-methyl-2-hexyl group, a 2-methylbutyl group, and a 2-methylpentyl group. Examples of those containing an oxygen atom include a 2-methoxyethyl group and a 2-ethoxyethyl group.
酸素原子を含んでいてもより直鎖もしくは分岐
鎖C3〜C8アルケニル基としては、例えば1−ブ
チルビニル,2−プロピルアリル,2−ペンテニ
ル,4−ペンテニル,2−メチル−3−ペンテニ
ル,4−ヘキセニル,1,4−ジメチル−3−ペ
ンテニル,5−ヘブテニル,1−メチル−5−ヘ
キセニル,6−メチル−5−ヘプテニル,2,6
−ジメチル−5−ヘプテニルなどが好ましい。 Examples of straight-chain or branched C3 - C8 alkenyl groups that contain an oxygen atom include, for example, 1-butylvinyl, 2-propylaryl, 2-pentenyl, 4-pentenyl, 2-methyl-3-pentenyl, 4 -hexenyl, 1,4-dimethyl-3-pentenyl, 5-hebutenyl, 1-methyl-5-hexenyl, 6-methyl-5-heptenyl, 2,6
-dimethyl-5-heptenyl and the like are preferred.
酸素原子を含んでいてもよい直鎖もしくは分岐
鎖C3〜C8アルキル基としては、例えば、2−ブ
チル,2−ペンチニル,3−ペンチニル,1−メ
チル−2−ペンチニル,1−メチル−3−ペンチ
ニルが好ましい。 Examples of the straight chain or branched C 3 -C 8 alkyl group which may contain an oxygen atom include 2-butyl, 2-pentynyl, 3-pentynyl, 1-methyl-2-pentynyl, 1-methyl-3 -Pentynyl is preferred.
置換フエニル基,置換フエノキシ基,もしくは
C3〜C10の置換シクロアルキル基の置換基として
は、例えばハロゲン原子,保護された水酸基(例
えばシリルオキシ基,C1〜C6アルコキシ基な
ど),C1〜C4アルキル基などが挙げられる。C3〜
C10のシクロアルキル基としては、例えばシクロ
プロピル基,シクロペンチル基,シクロヘキシル
基,シクロヘキセニル基,シクハヘプチル基,シ
クロオクチル基,シクロデシル基などを挙げるこ
とができる。シクロペンチル基,シクロヘキシル
基が好ましい。 Substituted phenyl group, substituted phenoxy group, or
Examples of substituents for the C3 to C10 substituted cycloalkyl group include halogen atoms, protected hydroxyl groups (e.g. silyloxy groups, C1 to C6 alkoxy groups, etc.), C1 to C4 alkyl groups, etc. . C 3 ~
Examples of the C 10 cycloalkyl group include a cyclopropyl group, a cyclopentyl group, a cyclohexyl group, a cyclohexenyl group, a cycloheptyl group, a cyclooctyl group, and a cyclodecyl group. Cyclopentyl group and cyclohexyl group are preferred.
C1〜C6アルコキシ基,置換されていてもよい
フエニル基,置換されていてもよいフエノキシ基
もしくは置換されていてもよいフエノキシ基、も
しくは置換されていてもよいC3〜C10シクロアル
キル基で置換されている直鎖もしくは分岐鎖C1
〜C5アルキル基において、C1〜C6アルコキシ基
としては、例えばメトキシ基,エトキシ基,プロ
ピルオキシ基,イテプロピルオキシ基,ブトキシ
基,t−ブトキシ基,ヘキシルオキシ基などが挙
げられる。置換されていてもよいフエニル基,置
換されていてもよいフエノキシ基,もしくは置換
されていてもよいC3〜C10シクロアルキル基の置
換基およびC3〜C10シクロアルキル基としては前
述の例示と同じものを挙げることができる。直鎖
もしくは分岐鎖C1〜C5アルキル基としては、例
えば、メチル基,エチル基,プロピル基,イソプ
ロピル基,ブチル基,イソブチル基,sec−ブチ
ル基,t−ブチル基,ペンチル基などを挙げるこ
とができる。これらの中でも、シクロヘキシル,
フエニル,フエノキシ,シクロペンチルメタル,
シクロヘキシルメチル基などを好ましいものとし
て挙げることができる。なお、置換基はその任意
の位置に結合していてもよい。 C 1 to C 6 alkoxy group, optionally substituted phenyl group, optionally substituted phenoxy group, or optionally substituted phenoxy group, or optionally substituted C 3 to C 10 cycloalkyl group Straight chain or branched chain C 1 substituted with
In the -C5 alkyl group, examples of the C1 - C6 alkoxy group include a methoxy group, an ethoxy group, a propyloxy group, an itepropyloxy group, a butoxy group, a t-butoxy group, and a hexyloxy group. As the optionally substituted phenyl group, the optionally substituted phenoxy group, or the optionally substituted C 3 to C 10 cycloalkyl group, the substituents and the C 3 to C 10 cycloalkyl group include the above-mentioned examples. The same thing can be mentioned. Examples of straight chain or branched C1 - C5 alkyl groups include methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, sec-butyl group, t-butyl group, pentyl group, etc. be able to. Among these, cyclohexyl,
phenyl, phenoxy, cyclopentyl metal,
Preferred examples include cyclohexylmethyl group. Note that the substituent may be bonded to any position thereof.
上記式〔〕においてnは0を表わすが、その
他の例として1であつてもよい。 In the above formula [], n represents 0, but may be 1 as another example.
また上記式〔〕においてR1およびR2は同一
もしくは異なり、水素原子,トリ(C1〜C7)炭
化水素シリル基を表わすが、その他の例として水
酸基の酸素原子とともにアセタール結合を形成す
る基もあげられる。ここでトリ(C1〜C7)炭化
水素シリル基および水酸基の酸素原子とともにア
セタール結合を形成する基としては上記式〔〕
の場合と同じものがあげられる。 In the above formula [], R 1 and R 2 are the same or different and represent a hydrogen atom or a tri(C 1 -C 7 ) hydrocarbon silyl group, but other examples include a group that forms an acetal bond with the oxygen atom of a hydroxyl group. You can also give Here, the group that forms an acetal bond with the tri(C 1 - C 7 ) hydrocarbon silyl group and the oxygen atom of the hydroxyl group is the above formula []
The same thing can be said for .
上記式〔〕で表わされるプロパルギルシクロ
ペンタン類を原料とする 環化反応に用いられる
還元剤の金属種としてアルカリ金属のリチウムナ
トリウム,カリウムなどをあげることができる
が、ナトリウムとリチウムが特に好ましい。ま
た、還元剤の金属種としてアルカリ土類金属のカ
ルシウム,マグネシウムをあげることができる。
かかるアルカリ金属またはアルカリ土類金属の使
用量は式〔〕で代表されるプロパルギルシクロ
ペンタン類1モルに対して1.0〜20.0倍モル、好
ましくは1.2〜10.0倍モル用いて行なわれる。 Examples of the metal species of the reducing agent used in the cyclization reaction using propargylcyclopentanes represented by the above formula [] include alkali metals such as lithium sodium and potassium, but sodium and lithium are particularly preferred. Further, examples of the metal species of the reducing agent include alkaline earth metals such as calcium and magnesium.
The amount of the alkali metal or alkaline earth metal to be used is 1.0 to 20.0 times, preferably 1.2 to 10.0 times, per mole of the propargylcyclopentane represented by formula [].
かかるアルカリ金属またはアルカリ土類金属の
還元剤はアニオンラジカル溶液として環化反応に
用いられる。アニオンラジカル溶液の溶媒として
は液体アンモニアまたはナフタレン,1−(N,
N−ジメチルアミノ)−ナフタレンまたは4,
4′−ジ−t−ブチルビフエニルをアルカリ金属ま
たはアルカリ土類金属と等モル以上に含有してい
るジエチルエーテル,テトラヒドロフラン,ジメ
トキシエタンなどのエーテル系溶媒が好ましく、
なかでもナフタレンまたは4,4′−ジ−t−ブチ
ルビフエニルを含有しているテトラヒドロフラン
が最も好ましい。その使用量は反応を円滑に進行
させるに十分な量があれば良く、通常は原料化合
物の1〜100倍容量、好ましくは2〜20倍容量が
用いられる。 Such an alkali metal or alkaline earth metal reducing agent is used in the cyclization reaction as an anion radical solution. Liquid ammonia or naphthalene, 1-(N,
N-dimethylamino)-naphthalene or 4,
Ether solvents such as diethyl ether, tetrahydrofuran, and dimethoxyethane containing 4'-di-t-butylbiphenyl in an amount equal to or more than the alkali metal or alkaline earth metal are preferred;
Among these, tetrahydrofuran containing naphthalene or 4,4'-di-t-butylbiphenyl is most preferred. The amount used is sufficient as long as the reaction proceeds smoothly, and usually 1 to 100 times the volume, preferably 2 to 20 times the volume of the raw material compound is used.
反応温度は−100℃〜100℃、好ましくは−78℃
〜50℃、特に好ましくは−78℃〜0℃程度の温度
範囲が採用される。反応時間は反応温度によつて
異なるが、通常−78℃〜0℃で数時間以内に反応
は終了する。 Reaction temperature is -100℃~100℃, preferably -78℃
A temperature range of about -50°C, particularly preferably -78°C to 0°C is employed. Although the reaction time varies depending on the reaction temperature, the reaction is usually completed within several hours at -78°C to 0°C.
また還元剤として用いられる金属種として亜鉛
も好ましく用いられる。かかる亜鉛による環化反
応は通常トリメチルクロルシランと塩基の共存下
に実施される。かかる亜鉛の使用量は式〔〕で
代表されるプロパルギルシクロペンタン類1モル
に対して1〜50倍モル、好ましくは10〜30倍モル
用いて行なわれる。また亜鉛は塩酸や銅,銀,水
銀等によつて活性化されたものが用いられる。ま
たトリメチルクロルシランは式〔〕で代表され
る化合物に対し1〜20倍モル好ましくは5〜10倍
モル用いられる。また塩基としては2,6−ルチ
ジンが好ましく用いられる。塩基は式〔〕で代
表される化合物に対して1〜10倍モル、好ましく
は1〜5倍モル用いられる。 Zinc is also preferably used as a metal species used as a reducing agent. Such a cyclization reaction using zinc is usually carried out in the presence of trimethylchlorosilane and a base. The amount of zinc to be used is 1 to 50 times, preferably 10 to 30 times, per mole of the propargylcyclopentane represented by formula []. Furthermore, zinc activated with hydrochloric acid, copper, silver, mercury, etc. is used. Further, trimethylchlorosilane is used in an amount of 1 to 20 times, preferably 5 to 10 times, the amount of the compound represented by formula []. Moreover, 2,6-lutidine is preferably used as the base. The base is used in an amount of 1 to 10 times, preferably 1 to 5 times, the amount of the compound represented by formula [].
かかる環化反応の溶媒としてはジエチルエーテ
ル,テトラヒドロフラン,ジメトキシエタンなど
のエーテル系溶媒が好ましく、すかでもテトラヒ
ドロフランが最も好ましい。その使用量は反応を
円滑に進行させるに充分な量があればよく、通常
は原料化合物の1〜100倍容量、好ましくは2〜
20倍容量が用いられる。 As the solvent for this cyclization reaction, ether solvents such as diethyl ether, tetrahydrofuran, and dimethoxyethane are preferred, and tetrahydrofuran is most preferred. The amount used should be sufficient for the reaction to proceed smoothly, and is usually 1 to 100 times the volume of the raw material compound, preferably 2 to 100 times the volume of the raw material compound.
20 times the volume is used.
反応温度は1℃〜100℃、好ましくは20℃〜80
℃程度の温度範囲が採用される。反応時間は反応
温度によつて異なるが通常20℃〜80℃で30分から
24時間以内で反応は終了する。 The reaction temperature is 1℃~100℃, preferably 20℃~80℃
A temperature range of about °C is adopted. The reaction time varies depending on the reaction temperature, but is usually 30 minutes at 20°C to 80°C.
The reaction is complete within 24 hours.
かくして得られた生成物は飽和塩化アンモニウ
ム水を用いたクエンチ,抽出等を行なうことによ
つて粗生生物として反応系からとり出すことがで
きる。粗生成物は所望により、カラムクロマトグ
ラフイー,薄層クロマトグラフイー,液体クロマ
トグラフイー,再結晶等の精製手段により精製す
ることができる。 The product thus obtained can be taken out from the reaction system as a crude organism by quenching and extraction using saturated ammonium chloride water. The crude product can be purified, if desired, by purification means such as column chromatography, thin layer chromatography, liquid chromatography, recrystallization, or the like.
かくして亜鉛を用いた環化反応によつて得られ
た生成物は下記式〔〕
〔式中、R11,R21,R3,R4およびnは前記定
義に同じ〕で表わされる化合物およびその鏡像体
あるいはそれらの任意の割合の混合物となつてい
る。 The product thus obtained by the cyclization reaction using zinc has the following formula [] It is a compound represented by the formula [wherein R 11 , R 21 , R 3 , R 4 and n are the same as defined above], its enantiomer, or a mixture thereof in any proportion.
このようにして生成した6,7−二置換−3−
メチレン−2−トリメチルシリルオキシビシクロ
〔3.3.0〕オクタン類の2位のトリメチルシリルエ
ーテルを加水分解して2−ヒドロキシ体にする方
法としては、通常のトリメチルシリルエーテル切
断用試剤たとえばテトラブチルアンモニウムフロ
リド(溶媒テトラヒドロフラン),p−トルエン
スルホン酸(溶媒メタノール),炭酸カリウム
(溶媒メタノール),クエン酸(溶媒メタノール),
p−トルエンスルホン酸−ピリジン(溶媒メタノ
ール)などを用いて実施することができる。すな
わち、下記する脱保護反応と同様に反応を行うこ
とによる目的とする化合物に変換することができ
る。 The 6,7-disubstituted-3- thus produced
As a method for hydrolyzing trimethylsilyl ether at the 2-position of methylene-2-trimethylsilyloxybicyclo[3.3.0]octanes to form a 2-hydroxy compound, a conventional trimethylsilyl ether cleaving reagent such as tetrabutylammonium fluoride (solvent tetrahydrofuran), p-toluenesulfonic acid (solvent methanol), potassium carbonate (solvent methanol), citric acid (solvent methanol),
It can be carried out using p-toluenesulfonic acid-pyridine (solvent methanol) or the like. That is, it can be converted into the desired compound by performing a reaction similar to the deprotection reaction described below.
式〔〕および〔〕で代表されるプロパルギ
ルシクロペンタン類および6,7−二置換−2−
ヒドロキシ−3−メチレンビシクロ〔3.3.0〕オ
クタン類の7位および6位の3′位(あるいは
4′位)が保護された水酸基の場合には、必要に応
じて脱保護することによつて遊離の水酸基とする
ことができる。 Propargylcyclopentanes represented by formulas [] and [] and 6,7-disubstituted-2-
Hydroxy-3-methylenebicyclo[3.3.0]octanes at position 7 and 3' of position 6 (or
If the hydroxyl group is protected at the 4' position, it can be deprotected as necessary to form a free hydroxyl group.
水酸基の保護基の除去は、保護基が水酸基の酸
素原子と共にアセタール結合を形成する基の場合
には、例えば酢酸,p−トルエンスメホン酸のピ
リジニウム塩または陽イオン交換樹脂等を触媒と
し、例えば水,テトラヒドロフラン,エチルエー
テル,ジオキサン,アセトン,アセトニトリル等
を反応溶媒とすることにより好適に実施される。
反応は通常−78℃〜+30℃の温度範囲で10分〜3
日間程度行なわれる。また、保護基がトリ(C1
〜C7)炭化水素 シリル基の場合には、例えば
酢酸,テトラブチルアンモニウムフルオライド,
セシウムフルオライド,フツ化水素,ピリジン−
フツ化水素の存在下に、上記したような反応溶媒
中で同様の温度で同様の時間実施される。 When the protecting group of the hydroxyl group is a group that forms an acetal bond with the oxygen atom of the hydroxyl group, the removal of the protecting group of the hydroxyl group is carried out using a catalyst such as acetic acid, a pyridinium salt of p-toluenesmephonic acid, or a cation exchange resin, etc. This reaction is preferably carried out using water, tetrahydrofuran, ethyl ether, dioxane, acetone, acetonitrile, or the like as a reaction solvent.
The reaction usually takes place in the temperature range of -78°C to +30°C for 10 minutes to 3
It is held for about a day. In addition, the protecting group is tri(C 1
~ C7 ) In the case of hydrocarbon silyl groups, examples include acetic acid, tetrabutylammonium fluoride,
Cesium fluoride, hydrogen fluoride, pyridine-
It is carried out in the presence of hydrogen fluoride in a reaction solvent as described above at a similar temperature and for a similar time.
また上記式〔〕,〔〕,〔〕で表わされる化
合物においてシクロペンタン環およびビシクロ
〔3.3.0〕エクタン環自身およびそれらの環上に結
合している置換基の結合している炭素は不斉な環
境のために立体異性体が存在するが、本発明では
いずれの立体異性体をも含むものであり、またこ
れらの任意の割合の立体異性体混合物でもさしつ
かえない。また式で代表される化合物とはこれら
の立体異性体すべて、およびそれらの異性体の任
意の割合の混合物をあらわすが、式であらわされ
た立体構造を有する化合物が最も好ましいものと
してあげられる。 Furthermore, in the compounds represented by the above formulas [], [], [], the carbon atoms to which the cyclopentane ring and bicyclo[3.3.0]ectane ring themselves and the substituents bonded to these rings are asymmetric. Although stereoisomers exist depending on the environment, the present invention includes any stereoisomers, and mixtures of these stereoisomers in arbitrary proportions are also acceptable. Further, the compound represented by the formula refers to all of these stereoisomers and a mixture of these isomers in any ratio, but the most preferred is a compound having the stereostructure represented by the formula.
本反応に用いられる上記式〔〕で表わされる
プロパルギルシクロペンタン類は下記式〔〕
〔式中、R11,R21,R3,R4およびnは前記定
義と同じ〕で表わされるプロパルギルシクロペン
タン類を酸化することによつて得ることができ
る。かかる酸化剤としては二酸化マンガン,クロ
ム酸,N−ハロカルボン酸アミド,酸素,2,3
−ジクロロ−5,6−ジシアノ−1,4−ベンゾ
キノン,ジメチルジスルホキシドなどをあげるこ
とができ、なかでも二酸化マンガン,クロム酸
(特にピリジニウムクロメート),ジメチルスルオ
キシドが好ましい。かかる酸化剤の使用量は原料
である式〔〕で表わされるシクロペンタン類1
モルに対して0.8〜20倍、好ましくは1.0〜10倍、
特に好ましくは1.2〜5倍モルの酸化剤を用いて
行なわれる。 The propargylcyclopentane represented by the above formula [] used in this reaction is the following formula [] It can be obtained by oxidizing propargylcyclopentanes represented by the formula [wherein R 11 , R 21 , R 3 , R 4 and n are the same as defined above]. Such oxidizing agents include manganese dioxide, chromic acid, N-halocarboxylic acid amide, oxygen, 2,3
-dichloro-5,6-dicyano-1,4-benzoquinone, dimethyl disulfoxide and the like, among which manganese dioxide, chromic acid (especially pyridinium chromate) and dimethyl sulfoxide are preferred. The amount of the oxidizing agent used is determined by the amount of cyclopentanes 1 represented by the formula []
0.8 to 20 times, preferably 1.0 to 10 times relative to the mole,
Particularly preferably, the oxidizing agent is used in an amount of 1.2 to 5 times the mole.
反応温度は用いる酸化剤によつて大いに異なり
−78℃〜120℃程度の温度範囲で実施され、反応
時間も酸化剤や反応温度により異なり薄層クロマ
トグラフイーなどで原料の消失を追跡しながら行
なうのが好ましい。 The reaction temperature varies greatly depending on the oxidizing agent used and is carried out in the temperature range of -78℃ to 120℃, and the reaction time also varies depending on the oxidizing agent and reaction temperature.The disappearance of raw materials is monitored using thin layer chromatography. is preferable.
反応は有機媒体中で行なわれるが、かかる有機
媒体としては工程1で例示したものゑ他にN,N
−ジメチルホルムアミド,アセトンなどの有機媒
体も適宜使用される。有機媒体の使用量は原料の
1〜100倍容量、好ましくは2〜20倍容量が用い
られる。 The reaction is carried out in an organic medium, such as those exemplified in step 1, as well as N, N,
- Organic media such as dimethylformamide and acetone are also used as appropriate. The amount of organic medium used is 1 to 100 times the volume of the raw material, preferably 2 to 20 times the volume.
後処理,分離,精製は前述と同様にして行なえ
る。 Post-treatment, separation, and purification can be performed in the same manner as described above.
上記式〔〕で表わされるプロパルギルシクロ
ペンタン類は下記式〔〕
[式中、R11,R21,R3,R4およびnは前記定
義に同じ。R5は水素原子またはトリメチルシリ
ル基を表わす。]
で表わされるプロパルギルシクロペンタン類をハ
イドロボレーシヨン反応及びそれに続く酸化反
応、またR5がトリメチルシリル基の場合にはさ
らにR5を選択的に脱保護することによつて得る
ことができる。ハイドロボレーシヨン反応は通常
の手法で実施することができる。〔オルガニツ
ク・リアクシヨン(Organic Reactions),13巻,
Chapter I,ジヨン・ウイリー・アンド・サン
ズ(John,Wiley&Sons Ine.)New York,
1963年;新実験化学講座,有機化合物の合成と反
応I,P497〜505,丸善等参照〕ハイドロボレー
シヨン試策としてはジアミルボラン((CH3)2
CHCH(CH3)BH),9−ボラビシクロ〔3.3.1〕
ノナン(9−BBN),ジシクロヘキシルボラン,
ジイソピノカンフエニルボラン等のジアルキルボ
ランやカテコールボラン,ジハロボラン等のジ置
換ボランを用いることができるが好ましくはジア
ミルボランおよび9−ボラビシクロ〔3.3.1〕ノ
ナン(9−BBN)が用いられる。ハイドロボレ
ーシヨンに続く酸化反応に使用される酸化剤とし
ては過酸化水素−水酸化ナトリウム,メチルアミ
ンオキシド,空気酸化等を用いることができるが
過酸化水素−水酸化ナトリウムが特に好ましい。
ハイドロボレーシヨン試薬の使用量は式〔〕で
表わされるシクロペンタン類に対して化学量論的
には等モルで反応は進行するが、通常は原料化合
物に対して0.5〜5倍モル、好ましくは0.8〜2倍
モル用いられる。反応温度は−100℃〜50℃、好
ましくは−20℃〜室温程度である。反応時間は反
応温度によつて異なるが、通常10分〜20時間、好
ましくは30分〜5時間程度である。反応は通常有
機媒体の存在下に行なわれる。用いられる媒体は
反応試剤とは反応しない不活性な非プロトン性有
機媒体が用いられ、好ましくはテトラヒドロフラ
ン,ジエチルエーテル,ジグリム,トリグラム等
のエーテル系溶媒が用いられ、特にテトラヒドロ
フランが好ましい。ハイドロボレーシヨン反応に
よつて生成するアルキルボランは通常単離するこ
となく、反応系に直接酸化剤を加えることにより
酸化して下記式〔′〕
〔式中,R11,R21,R3,R4およびnは前記定
義に同じ。〕
で表わされるアルコール体へと導かれる。酸化剤
として過酸化水素を用いる時は同時に水酸化ナト
リウム等の塩基を使用する。過酸化水素はいかな
る濃度のものでも使用できるが、30%前後の濃度
のものが一般的に使用される。過酸化水素の使用
量は使用するハイドロボレーシヨン試薬の0.5〜
50倍モル、好ましくは3〜10倍モルである。水酸
化ナトリウムはそのもの自体または水溶液として
使用することができるが、一般的に1〜10規定濃
度の水溶液を使用する。その使用量はハイドロボ
レーシヨン試薬の0.5〜50倍モル、好ましくは3
〜10倍モルである。この時の反応濃度は0℃〜
100℃であるが、好ましくは40℃〜70℃である。
反応時間は5分から5時間であるが、好ましくは
20分〜1時間である。酸化剤としてトリメチルア
ミンオキシドを用いる時は、通常ハイドロボレー
シヨン試薬に対して0.5〜50倍モル、好ましくは
3〜10倍モル用いる。 The propargylcyclopentane represented by the above formula [] is the following formula [] [In the formula, R 11 , R 21 , R 3 , R 4 and n are the same as defined above. R 5 represents a hydrogen atom or a trimethylsilyl group. ] The propargylcyclopentanes represented by the following can be obtained by a hydroboration reaction followed by an oxidation reaction, or further by selectively deprotecting R 5 when R 5 is a trimethylsilyl group. The hydroboration reaction can be carried out using conventional techniques. [Organic Reactions, Volume 13,
Chapter I, John, Wiley & Sons Ine. New York,
1963; New Experimental Chemistry Course, Synthesis and Reactions of Organic Compounds I, pp. 497-505, see Maruzen et al.] As a hydroboration test, diamylborane ((CH 3 ) 2
CHCH( CH3 )BH), 9-borabicyclo [3.3.1]
Nonane (9-BBN), dicyclohexylborane,
Dialkylborane such as diisopinocamphenylborane and disubstituted borane such as catecholborane and dihaloborane can be used, but diamylborane and 9-borabicyclo[3.3.1]nonane (9-BBN) are preferably used. As the oxidizing agent used in the oxidation reaction following hydroboration, hydrogen peroxide-sodium hydroxide, methylamine oxide, air oxidation, etc. can be used, but hydrogen peroxide-sodium hydroxide is particularly preferred.
The amount of hydroboration reagent used is stoichiometrically equivalent to the cyclopentane represented by the formula [], and the reaction proceeds, but it is usually 0.5 to 5 times the mole of the starting material compound, preferably 0.8 to 2 times the mole amount is used. The reaction temperature is about -100°C to 50°C, preferably about -20°C to room temperature. The reaction time varies depending on the reaction temperature, but is usually about 10 minutes to 20 hours, preferably about 30 minutes to 5 hours. The reaction is usually carried out in the presence of an organic medium. The medium used is an inert aprotic organic medium that does not react with the reaction reagent, preferably an ether solvent such as tetrahydrofuran, diethyl ether, diglyme, or trigram, with tetrahydrofuran being particularly preferred. The alkylborane produced by the hydroboration reaction is usually not isolated, but is oxidized by adding an oxidizing agent directly to the reaction system to form the following formula ['] [In the formula, R 11 , R 21 , R 3 , R 4 and n are the same as defined above. ] This leads to the alcohol form represented by . When hydrogen peroxide is used as an oxidizing agent, a base such as sodium hydroxide is used at the same time. Hydrogen peroxide can be used at any concentration, but concentrations around 30% are commonly used. The amount of hydrogen peroxide used is 0.5 to 0.5 of the hydroboration reagent used.
It is 50 times the molar amount, preferably 3 to 10 times the molar amount. Sodium hydroxide can be used as such or as an aqueous solution, but generally an aqueous solution with a concentration of 1 to 10 normal is used. The amount used is 0.5 to 50 times the mole of the hydroboration reagent, preferably 3
~10 times molar. The reaction concentration at this time is 0℃ ~
The temperature is 100°C, preferably 40°C to 70°C.
The reaction time is from 5 minutes to 5 hours, preferably
The duration is 20 minutes to 1 hour. When trimethylamine oxide is used as an oxidizing agent, it is usually used in an amount of 0.5 to 50 times, preferably 3 to 10 times, the amount of the hydroboration reagent.
かくして得られた生成物は、通常の方法に従つ
てクエンチ・抽出等をすることにより粗生成物と
して反応系から取り出すことができる。粗生成物
は、所望によりカラムクロマトグラフイー,薄層
クロマトグラフイー,液体クロマトグラフイー、
再結晶等の精製手段により精製することができ
る。 The product thus obtained can be taken out from the reaction system as a crude product by quenching, extraction, etc. in accordance with a conventional method. The crude product can be subjected to column chromatography, thin layer chromatography, liquid chromatography,
It can be purified by purification means such as recrystallization.
上記式〔〕で表わされる化合物は上記式
〔′〕で表わされる化合物のうちR5がトリメチ
ルシリル基であるものを選択的に脱保護すること
によつても得られる。このアセチレン末端の脱保
護反応は通常の手法で実施することができる〔シ
リコン・リエージエント・フオー・オルガニツ
ク・シンセシス(Silicon Reagents for
Organic Synthesis),Reactivity and Structure
Concepts Organic Chemistry 14巻,Chapter
9,Springer−Verlag,1983年〕脱保護反応試
薬としては硝酸銀−エタノール−水とシアン化カ
リウム−水を用いるもの、水酸化カリウム水,フ
ツ化カリウム−メタノールなどが用いられる。 The compound represented by the above formula [] can also be obtained by selectively deprotecting a compound represented by the above formula ['] in which R 5 is a trimethylsilyl group. This deprotection reaction of the acetylene terminal can be carried out by a conventional method [Silicon Reagents for Organic Synthesis].
Organic Synthesis),Reactivity and Structure
Concepts Organic Chemistry Volume 14, Chapter
9, Springer-Verlag, 1983] As deprotection reaction reagents, silver nitrate-ethanol-water, potassium cyanide-water, potassium hydroxide water, potassium fluoride-methanol, etc. are used.
上記式〔〕で表わされるプロパルギルシクロ
ペンタン類は下記式〔〕
[式中、R11,R21,R3,R4およびnは前後定
義に同じ。]
で表わされるプロパルギルシクロペンタノン類を
四塩化チタン−亜鉛−ジブロムメタンより調製さ
れるメチレン化剤(L.Lombardoら,テトラヘド
ロンレターズ,23巻,4293ページ,1982年参照),
四塩化チタン−亜鉛−ジヨードメタンより調製さ
れるメチレン剤(野崎一ら,テトラヘドロンレタ
ーズ,26巻,5581ページ,1985年参照)または他
のメチレン化剤を用いてメチレン化することによ
り得ることができる。 The propargylcyclopentane represented by the above formula [] is the following formula [] [In the formula, R 11 , R 21 , R 3 , R 4 and n are the same as defined before and after. ] A methylenating agent prepared from titanium tetrachloride-zinc-dibromomethane (see L. Lombardo et al., Tetrahedron Letters, Vol. 23, p. 4293, 1982),
It can be obtained by methylenation using a methylene agent prepared from titanium tetrachloride-zinc-diiodomethane (see Hajime Nozaki et al., Tetrahedron Letters, Vol. 26, p. 5581, 1985) or other methylenating agents. .
かかる四塩化チタン−亜鉛−ジプロムメチンよ
り調製されるメチレン化剤とはジプロムメタン1
gに対し、四塩化チタン0.5g〜2g,亜鉛0.8〜
2.5gより成る混合物をテトラヒドロフラン中0
℃で5時間〜3日間攪拌し放置したものを表わ
す。 The methylenating agent prepared from titanium tetrachloride-zinc-diprommethine is diprommethane 1.
per g, titanium tetrachloride 0.5g~2g, zinc 0.8~
A mixture consisting of 2.5 g of
It represents the product that was stirred and left at ℃ for 5 hours to 3 days.
また四塩化チタン−亜鉛−ジヨードメタンより
調製されるメチレン化剤とはジヨードメタン1g
に対し、四塩化チタン0.1〜0.2g,亜鉛0.3〜0.6
gよりなる混合物をテトラヒドロフラン中、25℃
で30分攪拌したものを表わす。 Also, the methylenating agent prepared from titanium tetrachloride-zinc-diiodomethane is 1g of diiodomethane.
For that, titanium tetrachloride 0.1-0.2g, zinc 0.3-0.6
g in tetrahydrofuran at 25°C.
This represents the result of stirring for 30 minutes.
上記式〔〕で表わされるシクロペンタノン類
とメチレン化剤との反応は有機媒体の存在下に行
なわれ、反応温度下において液状であつて反応試
薬とは反応しない不活性の非プロトン性の有機媒
体が用いられる。かかる媒体としてはジクロメタ
ン,ジクロルエタン,テトラクロルエタンの如き
ハロゲン化炭化水素が好ましく挙げられる。有機
媒体の使用量は反応を円滑に進行させるに十分な
量があればよく、通常は原料の1〜200倍容量,
好ましくは5〜50倍容量が用いられる。反応温度
は−20℃〜70℃,好ましくは0℃〜50℃で行なわ
れる。反応時間は10分〜24時間で終了する。かく
して得られた生成物は飽和炭酸水素ナトリウム水
によつてクエンチされ、抽出等をすることにより
反応系から取り出すことができる。粗生成物は所
望によりカラムクロマトグラフイー,薄層クロマ
トグラフイー,液体クロマトグラフイー,再結晶
等の精製手段により精製することができる。 The reaction between the cyclopentanones represented by the above formula [] and the methylenating agent is carried out in the presence of an organic medium. A medium is used. Preferred examples of such a medium include halogenated hydrocarbons such as dichloromethane, dichloroethane, and tetrachloroethane. The amount of organic medium used should be sufficient to allow the reaction to proceed smoothly, and is usually 1 to 200 times the volume of the raw materials.
Preferably, 5 to 50 times the volume is used. The reaction temperature is -20°C to 70°C, preferably 0°C to 50°C. The reaction time is 10 minutes to 24 hours. The product thus obtained is quenched with saturated aqueous sodium bicarbonate and can be extracted from the reaction system by extraction or the like. The crude product can be purified by purification means such as column chromatography, thin layer chromatography, liquid chromatography, recrystallization, etc., if desired.
上記式〔〕で表わされるプロパルギルシクロ
ペンタノン類は野依らの方法に従がい(野依良治
ら,ジヤーナル・オブ・アメリカン・ケミカル・
ソサイテイー,107巻,3348ページ,1985年)、下
記に示すごとく三成分連結反応を行なうことによ
り得ることができる。 The propargyl cyclopentanones represented by the above formula [ ] were prepared according to the method of Noyori et al. (Yoji Noyori et al., Journal of American Chemical
Society, Vol. 107, p. 3348, 1985) and can be obtained by performing a three-component ligation reaction as shown below.
[式中、R11,R21,R3,R4,R5およびnは前
後定義に同じ。]
かくの如く新規き環化反応によつて得られた式
〔〕で表わされる6,7−二置換−2−ヒドロ
キシ−3−メチレンビシクロ〔3.3.0〕オクタン
類は最初に述べた抗血栓剤等の医薬品として有用
なイソカルバサイクリンすなわち、9(O)−メタ
ノ−Δ6(9a)−プロスタグランジンI1類の中間体と
して有用である。すなわち式〔〕の6,7−二
置換−2−ヒドロキシ−3−メチレンビシクロ
〔3.3.0〕オクタン類(ただしR1,R2は各々前記定
義のR11,R21を表わすものとする)はそのアリ
ルアルコールのγ位で位置選択的に有機リチウム
化合物と反応して前述のイソカルバサイクリン、
すなわち9(O)−メタノ−Δ6(9a)−プロスタグラ
ンジンI1骨格を構築することができる有用な鍵中
間体である。 [In the formula, R 11 , R 21 , R 3 , R 4 , R 5 and n are the same as defined before and after. ] The 6,7-disubstituted-2-hydroxy-3-methylenebicyclo[3.3.0]octanes represented by the formula [] obtained by the novel cyclization reaction have the antithrombotic properties mentioned above. It is useful as an intermediate for isocarbacyclin, which is useful as a pharmaceutical agent such as 9(O)-methano-Δ 6(9a) -prostaglandin I class 1 . That is, 6,7-disubstituted-2-hydroxy-3-methylenebicyclo[3.3.0]octanes of the formula [] (wherein R 1 and R 2 represent R 11 and R 21 as defined above, respectively) reacts with an organolithium compound regioselectively at the γ-position of its allyl alcohol to form the above-mentioned isocarbacycline,
That is, it is a useful key intermediate capable of constructing the 9(O)-methano-Δ 6(9a) -prostaglandin I 1 skeleton.
<実施例>
以下、本発明を実施例により更に詳細に説明す
るが、本発明はこれらに限定されるものではな
い。<Examples> Hereinafter, the present invention will be explained in more detail with reference to Examples, but the present invention is not limited thereto.
下記式〔a〕から下記式〔a〕への環化反
応の例を実施例1〜4に示す。 Examples 1 to 4 show examples of the cyclization reaction from the following formula [a] to the following formula [a].
実施例 1
金属リチウム15mgとナフタレン266mgをテトラ
ヒドロフラン7mlに加えて、室温で2時間攪拌し
濃緑色にアニオンラジカル溶液を調製する。これ
を−50℃に冷却し、ここに〔a〕50mgのテトラ
ヒドロフラン3ml溶液を加える。5分後塩化アン
モニウム飽和水溶液を加えてクエンチし、酢酸エ
チルでの抽出も飽和食塩水での有機相洗浄後、硫
酸マグネシウムでの乾燥後溶媒を減圧濃縮して粗
生成物346mgを得た。これをシリカゲルカラムク
ロマトグラフイーによりヘキサン−酢酸エチル
9:1の混合溶媒で溶出させ〔a〕34mgを得
た。収率67%。 Example 1 15 mg of metallic lithium and 266 mg of naphthalene were added to 7 ml of tetrahydrofuran and stirred at room temperature for 2 hours to prepare a dark green anion radical solution. Cool this to -50°C, and add a solution of 50 mg of [a] in 3 ml of tetrahydrofuran. After 5 minutes, the mixture was quenched by adding a saturated aqueous ammonium chloride solution, extracted with ethyl acetate, washed the organic phase with saturated brine, dried over magnesium sulfate, and concentrated the solvent under reduced pressure to obtain 346 mg of a crude product. This was subjected to silica gel column chromatography eluting with a mixed solvent of hexane-ethyl acetate 9:1 to obtain 34 mg of [a]. Yield 67%.
この〔a〕は下記の〔aα〕14mgと〔aβ〕
20mgよりなる。 This [a] is the following [aα] 14mg and [aβ]
Consisting of 20mg.
スペクトルデータ
NMR (δCDCI3 TMS)〔aα〕〔aβ〕共通
0.8〜1.0(21H,m)3.5〜4.2(4H,br)
4.91(1H,brs),5.01(1H,brs),5.43
(2H,m)
Rf値(シリカゲル薄層クロマト,展開溶媒
n−ヘキサン−酢酸エチル4対1)
〔aα〕0.43,〔aβ〕0.30
実施例 2
金属リチウム15mgと4,4′−ジ−t−ブチルビ
フエニル553mgとテトラヒドロフラン5mlを0℃
で18時間攪拌し、濃緑色のアニオンラジカル溶液
を調製する。これを−50℃に冷却し〔a〕50.6
mgのテトラヒドロフラン3ml溶液を加える。5分
後実施例1と同様にクエンチ後処理,精製し、
〔a〕30mg(〔aα〕11mg,〔aβ〕19mgを得
た。収率59%。 Spectral data NMR (δ CDCI3 TMS ) [aα] [aβ] Common 0.8 to 1.0 (21H, m) 3.5 to 4.2 (4H, br) 4.91 (1H, brs), 5.01 (1H, brs), 5.43 (2H, m ) Rf value (silica gel thin layer chromatography, developing solvent n-hexane-ethyl acetate 4:1) [aα] 0.43, [aβ] 0.30 Example 2 15 mg of metallic lithium, 553 mg of 4,4'-di-t-butylbiphenyl, and tetrahydrofuran 5ml at 0℃
Stir for 18 hours to prepare a dark green anion radical solution. Cool this to -50℃ [a] 50.6
Add a solution of 1.0 mg in 3 ml of tetrahydrofuran. After 5 minutes, quench, post-process and purify in the same manner as in Example 1,
Obtained 30 mg of [a] (11 mg of [aα], 19 mg of [aβ]. Yield 59%.
実施例 3
金属ナトリウム14mgとナフタレン85mg,テトラ
ヒドロフラン2mlを室温で2.5時間攪拌しアニオ
ンラジカル溶液を調製する。これを−170℃に冷
却後〔a〕51mgのテトラヒドロフラン1.2ml溶
液を加えた。−70℃で1時間攪拌後、飽和塩化ア
ンモニウム水でクエンチし、実施例1と同じ操作
で後処理,精製して〔a〕25mg(〔aα〕7
mg,〔aβ〕18mg)を得た。収率42%。Example 3 An anion radical solution is prepared by stirring 14 mg of sodium metal, 85 mg of naphthalene, and 2 ml of tetrahydrofuran at room temperature for 2.5 hours. After cooling this to -170°C, a solution of 51 mg of [a] in 1.2 ml of tetrahydrofuran was added. After stirring at -70℃ for 1 hour, quenching with saturated ammonium chloride water, post-treatment and purification in the same manner as in Example 1, [a] 25 mg ([aα] 7
mg, [aβ] 18 mg). Yield 42%.
実施例 4
窒素ガス雰囲気下金属ナトリウム28mgを入れた
フラスコを−70℃に冷却し液体アンモニア約7ml
をとり攪拌しながら濃縮した。−45℃で〔a〕
51mgのテトラヒドロフラン3.5ml溶液をこれに加
え、そのまま50分攪拌した。この後安息香酸ナト
リウム432mgを加えて室温で20分攪拌とアンモニ
ア気化させた。水を加え、エーテルで2回抽出後
有機相を飽和重曹水,飽和塩化アンモニウム水,
食塩水の順で洗浄し、硫酸マグネシウムで乾燥
後、溶媒を減圧濃縮して48mgの粗生成物を得た。
シリカゲルカラムクロマトグラフイーにより、n
−ヘキサン−酢酸エチル97.5:2.5の混合溶媒で
溶出させ〔a〕(〔aβ〕のみ)10mgを得た。
収率20%。Example 4 A flask containing 28 mg of metallic sodium was cooled to -70°C under a nitrogen gas atmosphere, and about 7 ml of liquid ammonia was added.
The solution was taken and concentrated while stirring. -45℃〔a〕
A solution of 51 mg in 3.5 ml of tetrahydrofuran was added thereto, and the mixture was stirred for 50 minutes. After that, 432 mg of sodium benzoate was added, and the mixture was stirred at room temperature for 20 minutes and ammonia was vaporized. After adding water and extracting twice with ether, the organic phase was extracted with saturated sodium bicarbonate solution, saturated ammonium chloride solution,
After washing with brine and drying over magnesium sulfate, the solvent was concentrated under reduced pressure to obtain 48 mg of a crude product.
By silica gel column chromatography, n
Elution was performed with a mixed solvent of -hexane-ethyl acetate 97.5:2.5 to obtain 10 mg of [a] ([aβ] only).
Yield 20%.
下記式〔a〕から下記式〔a〕への環化反
応を経て〔a〕を得る例を実施例5〜8に示
す。 Examples 5 to 8 show examples of obtaining [a] through a cyclization reaction from the following formula [a] to the following formula [a].
実施例 5
亜鉛末を10%塩酸中5分攪拌する。上澄みをデ
カンテーシヨンで除いた後、水(1回),アセト
ン(3回),エーテル(2回)で洗浄後真空で2
時間乾燥活性化させた。〔a〕53mgにこの亜鉛
末138mgを加えさらにトリメチルクロルシラン68
mgのテトラヒドロフラン1ml溶液を加える更に
2,6−ルチジン32mgを加えて4時間加熱還流さ
せる。デカンテーシヨンで固体と液体を分離し、
液体側にジエチルエーテル10mlを加える有機相を
飽和硫酸水素カリウム水,飽和重曹水,食塩水の
順で洗い、硫酸マグネシウムで乾燥後、減圧で溶
媒を除去した。こうして得た〔a〕を含む粗生
成物をメタノール3mlに溶解し、p−トルエンス
ルホン酸ピリジン少々を加えて室温で10分間攪拌
する。ここに飽和重曹水を加え、メタノールを減
圧濃縮した後エーテル抽出を行なう。有機相を食
塩水で洗い、硫酸マグネシウムで乾燥後、溶媒を
減圧濃縮した。粗生成物をシリカゲルカラムクロ
マトグラフイーでn−ヘキサン−酢酸エチル19対
1の混合溶媒を用い、溶出させ〔a〕11.8mgを
得た。収率23%
実施例 6
亜鉛末を3%塩酸で1分間攪拌する。この洗浄
を4回繰返す。蒸留水で5回洗浄した後、2%硫
酸銅水溶液で2回洗浄、次いで蒸留水(5回),
無水エタノール(4回),ジエチルエーテル(5
回)の順序で洗い窒素ガス気流下にガラスフイル
ターで過し、減圧で4時間乾燥させて活性化し
た。 Example 5 Zinc powder is stirred in 10% hydrochloric acid for 5 minutes. After removing the supernatant by decantation, wash with water (1 time), acetone (3 times), and ether (2 times), and then evaporate in vacuum for 2 times.
Activated by drying for an hour. Add 138 mg of this zinc powder to [a] 53 mg and add 68 mg of trimethylchlorosilane.
1 ml of tetrahydrofuran is added, and 32 mg of 2,6-lutidine is added, and the mixture is heated under reflux for 4 hours. Decantation separates solids and liquids,
10 ml of diethyl ether was added to the liquid side. The organic phase was washed with saturated aqueous potassium hydrogen sulfate, saturated aqueous sodium bicarbonate, and brine in this order, dried over magnesium sulfate, and then the solvent was removed under reduced pressure. The crude product containing [a] thus obtained was dissolved in 3 ml of methanol, a small amount of pyridine p-toluenesulfonate was added, and the mixture was stirred at room temperature for 10 minutes. Saturated sodium bicarbonate solution is added thereto, methanol is concentrated under reduced pressure, and then ether extraction is performed. The organic phase was washed with brine, dried over magnesium sulfate, and the solvent was concentrated under reduced pressure. The crude product was eluted with silica gel column chromatography using a mixed solvent of n-hexane and ethyl acetate of 19:1 to obtain 11.8 mg of [a]. Yield: 23% Example 6 Zinc dust is stirred with 3% hydrochloric acid for 1 minute. Repeat this wash 4 times. After washing 5 times with distilled water, washing twice with 2% copper sulfate aqueous solution, then with distilled water (5 times),
Absolute ethanol (4 times), diethyl ether (5 times)
The mixture was washed in the order of 3 times), filtered through a glass filter under a stream of nitrogen gas, and activated by drying under reduced pressure for 4 hours.
〔a〕53mgに、この亜鉛末138mgとトリメチ
ルクロルシラン68mgのテトラヒドロフラン1ml溶
液,2,6−ルチジン32mgを加え、4時間加熱還
流させた。 To 53 mg of [a] were added a solution of 138 mg of this zinc powder and 68 mg of trimethylchlorosilane in 1 ml of tetrahydrofuran, and 32 mg of 2,6-lutidine, and the mixture was heated under reflux for 4 hours.
実施例5と同様の後処理,脱シリル化,精製を
行なつて〔a〕を16mg得た。収率31%。 The same post-treatment, desilylation and purification as in Example 5 were carried out to obtain 16 mg of [a]. Yield 31%.
実施例 7
亜鉛末350mgを10%塩酸で4分間攪拌後デカン
テーシヨンで上澄みを除く。アセトン,エーテル
の順で洗浄した後酢酸銀12mgの1.7ml沸騰酢酸懸
濁液を加え1分間攪拌した。注射器で上澄みを除
いた後、酢酸1ml,エーテル2ml(3回),メタ
ノール2ml,エーテル2ml(4回),テトラヒド
ロフラン2ml(4回)の順で洗浄後、真空で3時
間乾燥させて活性化した。Example 7 350 mg of zinc powder was stirred with 10% hydrochloric acid for 4 minutes, and then the supernatant was removed by decantation. After washing with acetone and ether in that order, a 1.7 ml suspension of 12 mg of silver acetate in boiling acetic acid was added and stirred for 1 minute. After removing the supernatant with a syringe, it was washed with 1 ml of acetic acid, 2 ml of ether (3 times), 2 ml of methanol, 2 ml of ether (4 times), and 2 ml of tetrahydrofuran (4 times), followed by activation by drying in vacuum for 3 hours. .
〔a〕53mgに、この亜鉛末138mgとトリメチ
ルクロルシラン68mgのテトラヒドロフラン1ml溶
液,2,6−ルチジン32mgを加え、4時間加熱還
流させた。実施例5と同様の後処理、脱シリル,
精製を行なつて〔a〕を18mg得た。収率34%
実施例 8
亜鉛末4.12gを10%塩酸で2分間攪拌し、上澄
みを除去した。蒸留水5mlによる洗浄を4回行な
つた後塩化第2水銀0.8gを5mlの沸騰水に溶液
を加えて10分間攪拌した。上澄みを除いた後、蒸
留水5ml,エタノール5ml(7回)エーテル5ml
(7回)の順で洗浄した。3時間真空乾燥させて
活性化亜鉛を調製した。 To 53 mg of [a] were added a solution of 138 mg of this zinc powder and 68 mg of trimethylchlorosilane in 1 ml of tetrahydrofuran, and 32 mg of 2,6-lutidine, and the mixture was heated under reflux for 4 hours. Post-treatment similar to Example 5, desilylation,
After purification, 18 mg of [a] was obtained. Yield: 34% Example 8 4.12 g of zinc powder was stirred with 10% hydrochloric acid for 2 minutes, and the supernatant was removed. After washing with 5 ml of distilled water four times, a solution of 0.8 g of mercuric chloride was added to 5 ml of boiling water and stirred for 10 minutes. After removing the supernatant, add 5 ml of distilled water, 5 ml of ethanol (7 times), and 5 ml of ether.
(7 times). Activated zinc was prepared by vacuum drying for 3 hours.
〔a〕53mgに、この亜鉛末138mgとトリメチ
ルクロルシラン68mgのテトラヒドロフラン1ml溶
液,2,6−ルチジン32mgを加え4時間加熱還流
させた。実施例5と同様の後処理,脱シリル,精
製を行なつて〔a〕を17mgを得た。収率32%。 To 53 mg of [a] were added a solution of 138 mg of this zinc powder and 68 mg of trimethylchlorosilane in 1 ml of tetrahydrofuran, and 32 mg of 2,6-lutidine, and the mixture was heated under reflux for 4 hours. The same post-treatment, desilylation and purification as in Example 5 were carried out to obtain 17 mg of [a]. Yield 32%.
次に下記式〔a〕から下記式〔a〕への酸
化反応の例を参考例1に示す。 Next, an example of the oxidation reaction from the following formula [a] to the following formula [a] is shown in Reference Example 1.
参考例 1
ピリジン5.05mlを50mlの塩化メチレンに溶解
し、三酸化クロム3.12gを加え20分間室温で攪拌
した。ここに〔a〕1.30gの塩化メチレン3ml
溶液を加え、室温で15分間攪拌した。エーテル
150mlを加え、セライト吸引過し固体を除去し
た。有機相を飽和硫酸水素カリウム水,飽和重曹
水,食塩水(2回)の順で洗浄した。硫酸マグネ
シウムで乾燥後減圧で溶媒を濃縮して1.32gの粗
生成物を得た。これをシリカゲルカラムクロマト
グラフイーで精製するとn−ヘキサン−酢酸エチ
ル(19対1)の溶出部に〔a〕1.01gを得た。
収率77%。 Reference Example 1 5.05 ml of pyridine was dissolved in 50 ml of methylene chloride, 3.12 g of chromium trioxide was added, and the mixture was stirred at room temperature for 20 minutes. Here [a] 1.30g of methylene chloride 3ml
The solution was added and stirred at room temperature for 15 minutes. ether
150 ml was added and filtered through Celite to remove solids. The organic phase was washed with saturated potassium hydrogen sulfate solution, saturated sodium bicarbonate solution, and brine (twice) in this order. After drying over magnesium sulfate, the solvent was concentrated under reduced pressure to obtain 1.32 g of crude product. When this was purified by silica gel column chromatography, 1.01 g of [a] was obtained in the n-hexane-ethyl acetate (19:1) eluate.
Yield 77%.
〔a〕のNMRスペクトルデータ δCDCI3 TMS:ppm 0.88(21H),2.87(1H,m), 3.7−4.3(2H,m),5.43 (2H,m),9.97(1H,d, J=3HZ)NMR spectrum data of [a] δ CDCI3 TMS : ppm 0.88 (21H), 2.87 (1H, m), 3.7−4.3 (2H, m), 5.43 (2H, m), 9.97 (1H, d, J=3HZ)
Claims (1)
リ(C1〜C7)炭化水素シリル基を表わし、R3は
水素原子を表わし、R4は直鎖もしくは分岐鎖C3
〜C8アルキル基を表わし、nは0を表わす。] で表わされる化合物およびその鏡像体あるいはそ
れらの任意の割合の混合物であるプロパルギルシ
クロペンタン類を金属種を用いる還元剤によつて
環化反応せしめ、また必要により脱保護反応せし
めることを特徴とする下記式[] [式中、R1,R2は同一もしくは異なり、水素
原子またはトリ(C1〜C7)炭化水素シリル基を
表わし、R3,R4およびnは前記定義に同じ。] で表わされる化合物およびその鏡像体あるいはそ
れらの任意の割合の混合物である6,7−二置換
−2−ヒドロキシ−3−メチレンビシクロ
[3.3.0]オクタン類の製造法。 2 還元剤として用いる金属類がアルカリ金属で
ある特許請求の範囲第1項記載の6,7−二置換
−2−ヒドロキシ−3−メチレンビシクロ
[3.3.0]オクタン類の製造法。 3 還元剤として用いられるアルカリ金属がナト
リウムまたはリチウムである特許請求の範囲第2
項記載の6,7−二置換−2−ヒドロキシ−3−
メチレンビシクロ[3.3.0]オクタン類の製造法。 4 還元剤として用いられる金属種がアルカリ土
類金属である特許請求の範囲第1項記載の6,7
−二置換−2−ヒドロキシ−3−メチレンビシク
ロ[3.3.0]オクタン類の製造法。 5 還元剤として用いられるアルカリ土類金属が
カルシウムまたはマグネシウムである特許請求の
範囲第4項記載の6,7−二置換−2−ヒドロキ
シ−3−メチレンビシクロ[3.3.0]オクタン類
の製造法。 6 還元剤として用いられる金属種が亜鉛である
特許請求の範囲第1項記載の6,7−二置換−2
−ヒドロキシ−3−メチレンビシクロ[3.3.0]
オクタン類の製造法。[Claims] 1. The following formula [] [In the formula, R 11 and R 21 are the same or different and represent a tri(C 1 to C 7 ) hydrocarbon silyl group, R 3 represents a hydrogen atom, and R 4 represents a straight or branched C 3
- represents a C8 alkyl group, and n represents 0. ] A compound represented by the formula and its enantiomers or propargylcyclopentanes, which are mixtures thereof in arbitrary proportions, are subjected to a cyclization reaction using a reducing agent using a metal species, and are also subjected to a deprotection reaction if necessary. The following formula [] [In the formula, R 1 and R 2 are the same or different and represent a hydrogen atom or a tri(C 1 to C 7 ) hydrocarbon silyl group, and R 3 , R 4 and n are the same as defined above. ] A method for producing 6,7-disubstituted-2-hydroxy-3-methylenebicyclo[3.3.0]octanes, which are a compound represented by the above, its enantiomer, or a mixture thereof in any proportion. 2. The method for producing 6,7-disubstituted-2-hydroxy-3-methylenebicyclo[3.3.0]octanes according to claim 1, wherein the metal used as the reducing agent is an alkali metal. 3 Claim 2 in which the alkali metal used as the reducing agent is sodium or lithium
6,7-Disubstituted-2-hydroxy-3- as described in
Method for producing methylenebicyclo[3.3.0]octanes. 4. 6, 7 according to claim 1, wherein the metal species used as the reducing agent is an alkaline earth metal.
-Production method of disubstituted-2-hydroxy-3-methylenebicyclo[3.3.0]octanes. 5. The method for producing 6,7-disubstituted-2-hydroxy-3-methylenebicyclo[3.3.0]octanes according to claim 4, wherein the alkaline earth metal used as the reducing agent is calcium or magnesium. . 6. 6,7-Disubstituted-2 according to claim 1, wherein the metal species used as the reducing agent is zinc.
-Hydroxy-3-methylenebicyclo[3.3.0]
Method for producing octanes.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61099470A JPS62258330A (en) | 1986-05-01 | 1986-05-01 | Production of 6,7-disubstituted-2-hydroxy-3-methylenebicyclo(3.3.0)octane |
EP87303883A EP0247740B1 (en) | 1986-05-01 | 1987-04-30 | Novel isocarbacyclins and processes for production thereof |
DE8787303883T DE3765181D1 (en) | 1986-05-01 | 1987-04-30 | ISOCARBACYCLINE AND METHOD FOR THEIR PRODUCTION. |
KR1019870004298A KR940003361B1 (en) | 1986-05-01 | 1987-05-01 | Novel isocarbacyclins and process for production thereof |
US07/044,957 US4788319A (en) | 1986-05-01 | 1987-05-01 | Novel isocarbacyclins and processes for production thereof |
US07/584,493 US5175338A (en) | 1986-05-01 | 1990-09-14 | Isocarbacyclin derivatives and their pharmaceutically acceptable salts thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61099470A JPS62258330A (en) | 1986-05-01 | 1986-05-01 | Production of 6,7-disubstituted-2-hydroxy-3-methylenebicyclo(3.3.0)octane |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4203564A Division JPH0751528B2 (en) | 1992-07-30 | 1992-07-30 | Propargyl cyclopentanes |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62258330A JPS62258330A (en) | 1987-11-10 |
JPH053863B2 true JPH053863B2 (en) | 1993-01-18 |
Family
ID=14248199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61099470A Granted JPS62258330A (en) | 1986-05-01 | 1986-05-01 | Production of 6,7-disubstituted-2-hydroxy-3-methylenebicyclo(3.3.0)octane |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62258330A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0664281B1 (en) * | 1992-10-05 | 1997-05-28 | Teijin Limited | ISOCARBACYCLIN WITH MODIFIED alpha(a)-CHAIN AND PROCESS FOR PRODUCING THE SAME |
-
1986
- 1986-05-01 JP JP61099470A patent/JPS62258330A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS62258330A (en) | 1987-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0045118B1 (en) | Intermediates for the synthesis of bicyclo (2,2,1) heptanes and bicyclo (2,2,1) hept-2z-enes | |
JPH053863B2 (en) | ||
JPH05301837A (en) | Propargylcyclopentanes | |
JP2664841B2 (en) | Process for producing 6,7-disubstituted-2-hydroxy-3-methylenebicyclo [3.3.0] octanes | |
JP5259045B2 (en) | Benzoprostacyclin intermediates and methods for their production | |
JPH01254635A (en) | Production of 6,7-disubstituted-2-hydroxy-3-methylenebicyclo(3,3,0)octanes | |
JP3712077B2 (en) | Hydroindan-4-ol derivative and method for producing the same | |
JP2788333B2 (en) | Method for producing cyclopentanols | |
JPH02104542A (en) | Production of 2-hydroxy-3-methylenebicyclo(3.3.0)-octanes | |
JPH0798796B2 (en) | Method for producing isocarbacyclines | |
JPH0220616B2 (en) | ||
US4927963A (en) | Novel processes for the synthesis of certain bicyclo(4.2.0)octane derivatives with valuable therapeutic properties | |
JP3471067B2 (en) | Method for producing optically active 6- (4-substituted inden-1-yl) -2-methyl-4-hepten-3-ols | |
JPH0645575B2 (en) | 3-Methylene-2,6,7-trisubstituted bicyclo [3.3.0 octanes | |
US6111125A (en) | Preparation of (1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl methyl ketone and derivatives and stereoisomers of this compound | |
JPS632251B2 (en) | ||
JPS5944336A (en) | Novel preparation of 2-allylcyclopentanones | |
JPH03220158A (en) | Preparation of optically active carbacycline derivative | |
JPH07233175A (en) | Asymmetric production of metal-substituted cyclopropylmethanol derivative. | |
JPS6377839A (en) | Production of isocarbacyclines | |
JPH0655715B2 (en) | 9-deoxo-6,9-dimethylene prostaglandin E1s | |
JPH0455422B2 (en) | ||
JPH07103066B2 (en) | Method for producing α-haloenone form | |
JPS62436A (en) | Production of optically active 4-hydroxy-2-cyclopentenone derivative | |
JPH04283526A (en) | Production of optically active allyl alcohol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |